Theme hub · 110 companies
Neuroscience stocks
Heavily traded in Neuroscience
Turnover over $10M/day27 of about 110 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| BIIBBiogen Inc. | $198.66M | +51.66% | Oct 29, 2026 |
| NBIXNeurocrine Biosciences, Inc. | $173.58M | +11.95% | Oct 28, 2026 |
| AXSMAxsome Therapeutics, Inc. | $156.70M | +85.47% | Nov 2, 2026 |
| PRAXPraxis Precision Medicines, Inc. | $116.77M | +717.18% | Nov 9, 2026 |
| 4523.TEisai Co., Ltd. | $6.82B | −5.01% | Nov 10, 2026 |
| TGTXTG Therapeutics, Inc. | $108.69M | +70.08% | Nov 2, 2026 |
| ALKSAlkermes plc | $72.07M | +72.81% | Oct 28, 2026 |
| XENEXenon Pharmaceuticals Inc. | $41.75M | +61.68% | Nov 2, 2026 |
BIIB+51.66%$198.66MView analysisNBIX+11.95%$173.58MView analysisAXSM+85.47%$156.70MView analysisPRAX+717.18%$116.77MView analysis4523.T−5.01%$6.82BView analysisTGTX+70.08%$108.69MView analysisALKS+72.81%$72.07MView analysisXENE+61.68%$41.75MView analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
110 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| UNC.DE | UCB SA | $56.26B | Large cap | +3.72% |
| BIIB34.SA | Biogen Inc. | $32.57B | Large cap | +45.02% |
| BIIB | Biogen Inc. | $32.12B | Large cap | +51.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.98B | Large cap | +11.95% |
| AXSM | Axsome Therapeutics, Inc. | $11.34B | Large cap | +85.47% |
| PRAX | Praxis Precision Medicines, Inc. | $9.23B | Mid cap | +717.18% |
| 4523.T | Eisai Co., Ltd. | $8.70B | Mid cap | −5.01% |
| TGTX | TG Therapeutics, Inc. | $8.27B | Mid cap | +70.08% |
| ALKS | Alkermes plc | $7.69B | Mid cap | +72.81% |
| XENE | Xenon Pharmaceuticals Inc. | $5.64B | Mid cap | +61.68% |
| ACAD | ACADIA Pharmaceuticals Inc. | $4.71B | Mid cap | +11.55% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.64B | Mid cap | −28.82% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.59B | Mid cap | −6.94% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.07B | Mid cap | +48.61% |
| DNLI | Denali Therapeutics Inc. | $3.39B | Mid cap | +61.25% |
| BIOA-B.ST | BioArctic AB (publ) | $2.96B | Mid cap | +19.07% |
| RGC | Regencell Bioscience Holdings Limited | $2.84B | Mid cap | −60.00% |
| NAMS | NewAmsterdam Pharma Company N.V. | $2.67B | Mid cap | −7.30% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.42B | Mid cap | +27.82% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.41B | Mid cap | −5.68% |
| RAPP | Rapport Therapeutics, Inc. | $2.11B | Mid cap | +77.92% |
| BHVN | Biohaven Ltd. | $1.91B | Small cap | −8.01% |
| LBRX | LB Pharmaceuticals Inc | $1.45B | Small cap | +168.34% |
| SPTX | Seaport Therapeutics, Inc. | $1.32B | Small cap | +24.50% |
| ANRO | Alto Neuroscience, Inc. | $1.24B | Small cap | +740.32% |
| ALMS | Alumis Inc. | $1.19B | Small cap | +110.50% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.08B | Small cap | −6.99% |
| MEDCL.PA | MedinCell S.A. | $903.34M | Small cap | +9.73% |
| ACHV | Achieve Life Sciences, Inc. | $743.98M | Small cap | +137.83% |
| 4565.T | Nxera Pharma Co., Ltd. | $730.77M | Small cap | +25.20% |
| COLL | Collegium Pharmaceutical, Inc. | $707.09M | Small cap | −34.68% |
| BHVN34.SA | Biohaven Ltd. | $695.05M | Small cap | −12.20% |
| DRUG | Bright Minds Biosciences Inc. | $621.89M | Small cap | +30.25% |
| MPLT | MapLight Therapeutics, Inc. | $609.87M | Small cap | −28.30% |
| CTNM | Contineum Therapeutics, Inc. | $557.55M | Small cap | +19.61% |
| OVID | Ovid Therapeutics Inc. | $535.12M | Small cap | +114.06% |
| PRTA | Prothena Corporation plc | $454.85M | Small cap | +8.58% |
| BIOA | BioAge Labs, Inc. | $389.21M | Small cap | +76.67% |
| DMAC | DiaMedica Therapeutics Inc. | $353.21M | Small cap | −6.56% |
| VNDA | Vanda Pharmaceuticals Inc. | $311.38M | Small cap | +17.58% |
| ALEC | Alector, Inc. | $246.76M | Small cap | −25.34% |
| AVXL | Anavex Life Sciences Corp. | $241.01M | Small cap | −71.38% |
| NGEN | NervGen Pharma Corp. | $236.01M | Small cap | −20.76% |
| CLN.WA | Celon Pharma S.A. | $225.65M | Small cap | −0.90% |
| ABOS | Acumen Pharmaceuticals, Inc. | $201.77M | Small cap | +121.43% |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $201.18M | Small cap | −57.73% |
| NERV | Minerva Neurosciences, Inc. | $191.47M | Small cap | +78.22% |
| ACOG | Alpha Cognition Inc. | $189.69M | Small cap | −7.83% |
| NMRA | Neumora Therapeutics, Inc. | $187.78M | Small cap | −34.28% |
| ACW.AX | Actinogen Medical Limited | $160.07M | Small cap | +84.37% |
| IMUX | Immunic, Inc. | $153.23M | Small cap | +45.28% |
| NRXP | NRx Pharmaceuticals, Inc. | $151.10M | Small cap | +16.33% |
| NYR.AX | Nyrada Inc. | $122.75M | Small cap | +139.66% |
| PMN | ProMIS Neurosciences, Inc. | $118.91M | Small cap | +26.29% |
| TLSA | Tiziana Life Sciences Ltd | $113.29M | Small cap | −47.65% |
| COYA | Coya Therapeutics, Inc. | $108.84M | Small cap | −18.31% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $96.29M | Micro cap | +204.09% |
| CGTX | Cognition Therapeutics, Inc. | $96.04M | Micro cap | −34.42% |
| HLS.TO | HLS Therapeutics Inc. | $92.36M | Micro cap | −26.02% |
| MNOV | MediciNova, Inc. | $92.04M | Micro cap | +50.81% |
| DICOT.ST | Dicot Pharma AB | $86.13M | Micro cap | −69.68% |
| NTRB | Nutriband Inc. | $84.18M | Micro cap | +2.74% |
| AB.PA | AB Science S.A. | $80.25M | Micro cap | −41.32% |
| GANX | Gain Therapeutics, Inc. | $75.94M | Micro cap | +6.10% |
| CING | Cingulate Inc. | $75.18M | Micro cap | +32.23% |
| LONA | LeonaBio, Inc. | $70.38M | Micro cap | +94.53% |
| ATHE | Alterity Therapeutics Limited | $70.28M | Micro cap | −16.81% |
| ATH.AX | Alterity Therapeutics Limited | $67.02M | Micro cap | −14.00% |
| INMB | INmune Bio Inc. | $64.67M | Micro cap | +12.69% |
| DWTX | Dogwood Therapeutics, Inc. | $62.72M | Micro cap | −62.11% |
| SER | Serina Therapeutics, Inc. | $62.23M | Micro cap | −51.68% |
| ANVS | Annovis Bio, Inc. | $48.57M | Micro cap | −52.30% |
| NUZ.AX | Neurizon Therapeutics Limited | $43.15M | Micro cap | −45.71% |
| CLNN | Clene Inc. | $42.14M | Micro cap | −47.52% |
| CRVO | CervoMed Inc. | $38.25M | Micro cap | −70.37% |
| 4891.T | TMS Co., Ltd. | $37.12M | Micro cap | −19.48% |
| BXT.DE | BioNxt Solutions Inc. | $36.76M | Micro cap | −41.18% |
| FLNA | Filana Therapeutics, Inc. | $34.72M | Micro cap | −65.38% |
| MIRA | MIRA Pharmaceuticals, Inc. | $31.63M | Micro cap | −45.43% |
| IGC | IGC Pharma, Inc. | $28.48M | Micro cap | −33.33% |
| 4586.T | MedRx Co., Ltd | $25.44M | Micro cap | −41.75% |
| QNTM | Quantum BioPharma Ltd. | $22.25M | Micro cap | −80.11% |
| NEUP | Neuphoria Therapeutics Inc. | $20.54M | Micro cap | −68.52% |
| 0R3M.L | Vivoryon Therapeutics N.V. | $20.24M | Micro cap | −31.68% |
| LPCN | Lipocine Inc. | $18.30M | Micro cap | −25.25% |
| NSB.AX | NeuroScientific Biopharmaceuticals Limited | $17.33M | Micro cap | −64.24% |
| BIVI | BioVie Inc. | $17.32M | Micro cap | +16.48% |
| AGN.AX | Argenica Therapeutics Limited | $16.04M | Micro cap | −45.16% |
| CYCN | Cyclerion Therapeutics, Inc. | $15.73M | Micro cap | +914.41% |
| AELIS.PA | Aelis Farma SA | $14.96M | Micro cap | −25.65% |
| ADIL | Adial Pharmaceuticals, Inc. | $14.67M | Micro cap | −42.86% |
| SCNX | Scienture Holdings, Inc. | $13.92M | Micro cap | −65.51% |
| NRSN | NeuroSense Therapeutics Ltd. | $13.09M | Micro cap | +494.83% |
| SVNS.L | Solvonis Therapeutics plc | $12.26M | Micro cap | −63.49% |
| ALNFL.PA | NFL Biosciences SA | $12.00M | Micro cap | −36.56% |
| VTGN | Vistagen Therapeutics, Inc. | $10.79M | Micro cap | −92.62% |
| ALZ.ST | Alzinova AB (publ) | $9.64M | Micro cap | −58.94% |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. | $9.37M | Micro cap | −95.77% |
| ENSC | Ensysce Biosciences, Inc. | $9.37M | Micro cap | −76.76% |
| ALZN | Alzamend Neuro, Inc. | $8.45M | Micro cap | −25.53% |
| IXC.AX | Invex Therapeutics Ltd | $6.16M | Micro cap | +4.55% |
| TCF.L | Theracryf Plc | $5.37M | Micro cap | −26.00% |
| JUNS | Jupiter Neurosciences, Inc. | $4.50M | Micro cap | +113.12% |
| ADXN | Addex Therapeutics Ltd | $4.41M | Micro cap | −63.83% |
| BTAI | BioXcel Therapeutics, Inc. | $2.31M | Micro cap | −98.42% |
| OGEN | Oragenics, Inc. | $2.25M | Micro cap | −60.63% |
| ADXN.SW | Addex Therapeutics Ltd | — | — | −64.35% |
| IDIA.SW | Idorsia Ltd | — | — | +19.19% |
| MMTX.SW | MindMaze Therapeutics Holding SA | — | — | −84.15% |
| NWRN.SW | Newron Pharmaceuticals S.p.A. | — | — | +19.24% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 110 companies grouped under the Neuroscience theme. The median market value in the group is $120.83M. Across the group, the median move over the past trading day is 0.00%. 41% of the 106 with a 200-day average trade above it. Price change over the past year runs from −65.4% to +110.8% across the middle 80 percent of the group, with a median of −7.1%.
Other lists in this group
NeuroscienceAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind